between who has what vaccines i wonder about this. because what happens over seas eventually comes here. that s part of the problem. so are there any caveats on the moderna news, number one? first of all, as a practical matter how do you read that news about the vaccines a lot of people have here, the mrna vaccines. and secondly, how do we feel with this larger question of global health where everybody is interconnected but the distribution of vaccines is eneven and different and have different levels of efficacy against this particular variant. to answer your first question, this theus about the moderna vaccine, having w the booster dose being very effective, giving you threefold antibodies to be able to protect yourself against covid, that s great news w. the full dose it even is up to 80fold greater. that s fantastic news. but this is all hypothetical. we need to actually see what happens in real life.
The drugmaker said Thursday that longer delivery lead times for exports and a temporary impact from expanding its fill-finish capacity may shift some deliveries to early 2022.
US: Scientists at the U.S. Food and Drug Administration said on Tuesday that Moderna Inc had not met all of the agency s criteria to support use of booster doses of its COVID-19 vaccine, possibly.
it has major implications for our children. moderna filed for emergency use authorization for their covid vaccine between the ages of 12 and 17. this would dramatically expand the number of shots available to middle and high school students ahead of the next school year. it comes as the fda is meeting at this very moment to decide exactly what information companies need to provide for full fda approval of their vaccines in kids. i want to bring in medical correspondent dr. john torres for more. let s start with the moderna news. how big of a deal would it be to have another potentially approved shot for kids between 12 and 17? it s like you said, it would greatly expand the amount of vaccines available right now. it looks like this could be happening hopefully over the next month or so. if you look at pfizer, they